Mechanisms in the Pathogenesis of Asbestosis and Silicosis
about
Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cellAirborne nanostructured particles and occupational healthOxidative stress and dermal toxicity of iron oxide nanoparticles in vitroNew perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsPotential pulmonary effects of man-made organic fiber (MMOF) dustsPotential for diffuse parenchymal lung disease after exposures at World Trade Center disaster siteSingle- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans?Role of inducible nitric oxide synthase-deried nitric oxide in silica-induced pulmonary inflammation and fibrosisExercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseasesTowards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesLung cancer: epidemiology, etiology, and preventionSilica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationAsbestos: mining exposure, health effects and policy implicationsThe Nalp3 inflammasome is essential for the development of silicosisThe significance of nanoparticles in particle-induced pulmonary fibrosisInnate immune activation through Nalp3 inflammasome sensing of asbestos and silicaPulmonary inflammation and crystalline silica in respirable coal mine dust: dose-responseOncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cellsInterleukin-12 is not essential for silicosis in mice.Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidenceRole of oxidants in interstitial lung diseases: pneumoconioses, constrictive bronchiolitis, and chronic tropical pulmonary eosinophiliaEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesThe phagocytosis and toxicity of amorphous silicaSystemic inhibition of NF-kappaB activation protects from silicosisCurrent investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitationsPutting tumours in contextSilica-induced NLRP3 inflammasome activation in vitro and in rat lungsDifferences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cellsTargeting the MEK1 cascade in lung epithelium inhibits proliferation and fibrogenesis by asbestosQuantification of particle-induced inflammatory stress response: a novel approach for toxicity testing of earth materialsThe mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cellsThe alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticlesA protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestosAssessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassaysAsbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsTNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesisRoles of microRNA-146a and microRNA-181b in regulating the secretion of tumor necrosis factor-α and interleukin-1β in silicon dioxide-induced NR8383 rat macrophagesPulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestosRole of mutagenicity in asbestos fiber-induced carcinogenicity and other diseasesLength-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura
P2860
Q22305707-9484770F-D46B-4598-AD44-05B8279EDCF6Q23909885-BFCDC115-6082-42FA-BFAB-DB02E87A67B1Q23910151-ECE20C9C-8BF0-49AA-831B-F89F6952067CQ23910479-35274749-964C-4C25-855C-3FDB43CE4925Q23911507-7DCC95F7-5EBC-4C7B-AAE8-B2D282EAEACDQ23914191-63CF2F76-4791-49B5-ABF8-0716546B815EQ23917643-0D5BAE96-52C6-42DA-AF4F-03E1F0B84E88Q23919193-9CDC2866-3A0A-4928-8FF0-8AEBE13C4C81Q24187975-F9D8595A-5F20-4020-8B6E-9808C04119B1Q24289511-E95C0EBB-1B5C-4276-84C9-8D6CE75E5818Q24630167-B204F432-93A6-4B24-8CF4-412A943F999EQ24631966-8A32E8FD-960D-4C2B-B19B-D1FC913012D8Q24645070-B6C936B1-5861-44FA-ABD9-D56CD7F48F0DQ24645580-6A29C1CF-1734-4164-B210-936D128B0C28Q24645647-9F59C9B6-45E2-404A-B507-44B1E5773094Q24649598-CB853A30-A889-4530-AAEC-AF3C7A7CC893Q24704010-9487B230-2EEA-4EBC-99CA-B083C643C36BQ24719459-29592442-729A-4010-871D-BC250715851CQ25257003-DEBD1828-19B0-4D03-BF9E-7EB029938880Q26206514-9004BE47-AC07-468F-9372-C48EE23C7BF4Q26824848-0A1F7198-67EF-4BA9-93B5-228E6A75180DQ27023830-3A74CDC6-2E34-4555-B29A-9494DECC1E7DQ27314583-F7E8D29F-6DF9-4193-9EA9-274D7DB7BA64Q27349064-429A29C8-1334-4903-A638-C06ED1D81561Q28087733-8D6FD577-6436-4234-9C7C-DA667CA7D6F7Q28207789-BBFFA834-3782-4423-8C68-0E550A810036Q28382977-1AF5788B-A445-432C-99F1-54CD7C895F15Q28383808-C2405F35-2FFF-4598-898A-5F60FFF9CA98Q28384049-106C7C0E-66C0-4089-8099-4333AD3778B9Q28384367-256559ED-8F3D-4692-90E5-358A9A373FF0Q28384396-249E62A6-2B81-4533-BA68-E596A544A8C3Q28385117-5B42624B-367A-42BA-8CA8-51705B6CE750Q28387182-0C4F6980-14A0-4BE7-8A6B-5E907AF3F142Q28387399-6F754616-B4B1-4D61-A9A8-551683D0588DQ28387699-712E4E18-E5B1-4071-87E1-CD1538D32FB0Q28389414-CAEE5A95-5B09-47CC-BF55-DD650B7A96BFQ28389474-02F6D548-B4DD-4C72-BE2E-136A4DEA4F5EQ28389546-E4CA9F07-7648-486C-A5A3-420CF71EBDAFQ28389566-A0A6A94F-AC00-4A2A-BB4B-43D5BA28BAD0Q28389843-30E32BFA-C189-4435-A7F6-C51C01C6498E
P2860
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@ast
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en-gb
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@nl
type
label
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@ast
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en-gb
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@nl
altLabel
Mechanisms in the pathogenesis of asbestosis and silicosis
@en
prefLabel
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@ast
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en-gb
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@nl
P921
P3181
P1476
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
@en
P2093
ANDREW CHURG
BROOKE T. MOSSMAN
P304
P3181
P356
10.1164/AJRCCM.157.5.9707141
P407
P577
1998-05-01T00:00:00Z